Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celladon's stock craters after disappointing trial results, downgrade
Celladon's stock craters after disappointing trial results, downgrade
Celladon's stock craters after disappointing trial results, downgrade
Submitted by
admin
on April 27, 2015 - 10:01am
Source:
Marketwatch
News Tags:
Celladon
heart faliure
Mydicar
Headline:
Celladon's stock craters after disappointing trial results, downgrade
Do Not Allow Advertisers to Use My Personal information
